Skip to search.
 FTSE 100 Down 0.28%

Kite Pharma, Inc. (KITE)

-NasdaqGS
57.88 Up 0.38(0.66%) 21:00
Prev Close:57.50
Open:57.59
Bid:57.78 x 200
Ask:58.04 x 100
1y Target Est:72.42
Beta:N/A
Earnings Date:10 Nov - 14 Nov (Est.)
Day's Range:56.39 - 59.46
52wk Range:38.41 - 89.84
Volume:672,876
Avg Vol (3m):858,661
Market Cap:2.87b
P/E (ttm):N/A
EPS (ttm):-3.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for KITE at this time.

Comparison

Symbol% ChgMkt Cap
KITEUp 0.66%2.87b
PFEDown 0.14%210.90b
CELGDown 2.43%83.64b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):143.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-5.83
Quarterly EPS Est (Sep-16) :-1.63
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback